MDxHealth SA (MDXH) FinancialsMDXHMDxHealth SA

In the context of the broader market, MDXH competes directly with industry leaders such as RVP and PAVM. With a market capitalization of $17.56M, it holds a significant position in the sector. When comparing efficiency, MDXH's gross margin of N/A stands against RVP's 2.65% and PAVM's -269.70%. Such benchmarking helps identify whether MDxHealth SA is trading at a premium or discount relative to its financial performance.

MDxHealth's revenue for Q2 2026 was $27.2 million, a 16% increase year-over-year, but it reported a net income loss of $11.5 million. The gross margin improved to 61.13%, but the company is still struggling with significant operational losses.